Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

James L. Gulley, Jeffrey Schlom, Vittore Cereda et al.|Cancer Immunology Immunotherapy|2009

Cited by 298